Oncologists’ reflections on patient rights and access to compassionate use drugs: A qualitative interview study from an academic cancer center

The U.S. Food and Drug Administration (FDA) allows patients with serious illnesses to access investigational drugs for “compassionate use” outside of clinical trials through expanded access (EA) Programs. The federal Right-to-Try Act created an additional pathway for non-trial access to experimental...

Descripción completa

Detalles Bibliográficos
Autores principales: Stout, Jeremiah, Smith, Cambray, Buckner, Jan, Adjei, Alex A., Wentworth, Mark, Tilburt, Jon C., Master, Zubin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8682887/
https://www.ncbi.nlm.nih.gov/pubmed/34919568
http://dx.doi.org/10.1371/journal.pone.0261478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8682887/
https://www.ncbi.nlm.nih.gov/pubmed/34919568
http://dx.doi.org/10.1371/journal.pone.0261478

Ejemplares similares